Cardinal Health, Inc. (CAH) Q1 2023 Earnings Call Transcript
Cardinal Health, Inc. (NYSE:CAH) Q1 2023 Earnings Conference Call November 4, 2022 8:30 AM ET
Company Participants
Kevin Moran - Vice President of Investor Relations
Jason Hollar - Chief Executive Officer
Trish English - Interim Chief Financial Officer
Conference Call Participants
Elizabeth Anderson - Evercore
Lisa Gill - JPMorgan
Kevin Caliendo - UBS
Erin Wright - Morgan Stanley
Michael Cherny - Bank of America
Eric Percher - Nephron Research
George Hill - Deutsche Bank
A.J. Rice - Credit Suisse
Charles Rhyee - Cowen
Steven Valiquette - Barclays
Operator
Good day, and welcome to the First Quarter Fiscal Year 2023 Cardinal Health Earnings Conference Call. Today's call is being recorded.
I will now hand the call over to Kevin Moran, Vice President of Investor Relations. Please go ahead, sir
Kevin Moran
Good morning, and welcome. Today, we will discuss Cardinal Health's first quarter fiscal 2023 results, along with updates to our full year outlook. You can find today's press release and earnings presentation on the IR section of our website at ir.cardinalhealth.com. Joining me today are Jason Hollar, Chief Executive Officer; and Trish English, Interim Chief Financial Officer.
During the call, we will be making forward-looking statements. The matters addressed in the statements are subject to the risks and uncertainties that could cause actual results to differ materially from those projected or implied. Please refer to our SEC filings and the forward-looking statement slide at the beginning of our presentation for a full description of these risks and uncertainties.
Please note that during the discussion today, our comments will be on a non-GAAP basis, unless they are specifically called out as GAAP. GAAP to non-GAAP reconciliations for all relevant periods can be found in the schedules attached to our press release. During the Q&A portion of today's call, we please ask that you try and limit yourself to one question so that we can try and give everyone in the queue an opportunity.
With that, I'll now turn the call over to Jason.
Jason Hollar
Thanks, Kevin, and good morning, everyone. Now that I've had a couple of months to settle into the CEO role, I'm feeling even more energized and excited about the opportunities in front of us. By recent conversations with customers, suppliers, employees and shareholders have reinforced my perceptions that our company's role in healthcare and our mission to improve the lives of people every day remain as critical as ever.